Login / Signup

Surgery of the primary tumor in patients with de novo metastatic breast cancer: a nationwide population-based retrospective cohort study in Belgium.

Mariana BrandãoDiogo Martins-BrancoClaudia De AngelisPeter VuylstekeRichard D GelberNancy Van DammeLien van WalleArlindo R FerreiraMatteo LambertiniFrancesca PoggioDidier VerhoevenAnnelore BarbeauxFran Ois P DuhouxHans P M W WildiersCarmela CaballeroAhmad AwadaMartine J PiccartKevin PunieEvandro de Azambuja
Published in: Breast cancer research and treatment (2023)
Among patients receiving systemic treatment for de novo metastatic breast cancer and surviving nine months or more, those who received surgery of the primary tumor within nine months of diagnosis have longer subsequent survival than those who did not.
Keyphrases
  • metastatic breast cancer
  • minimally invasive
  • coronary artery bypass
  • surgical site infection
  • percutaneous coronary intervention
  • free survival